Literature DB >> 27293114

Pregnancy is a model for tumors, not transplantation.

Kenneth D Beaman1, Mukesh K Jaiswal1, Gajendra K Katara1, Arpita Kulshreshta1, Sahithi Pamarthy1, Safaa Ibrahim1, Joanne Kwak-Kim1, Alice Gilman-Sachs1.   

Abstract

Nearly 65 years have passed since Peter Medawar posed the following question: "How does the pregnant mother contrive to nourish within itself, for many weeks or months, a fetus that is an antigenically foreign body." Now, understanding of reproductive immunology has demonstrated that the HLA antigens in the placenta are non-classical and do not induce rejection. In the placenta and in tumors, 50% or more of the cells are cells of the immune system and were once thought to be primed and ready for killing tumors or the "fetal transplant" but these cells are not potential killers but abet the growth of either the tumor or the placenta. We believe that these cells are there to create an environment, which enhances either placental or tumor growth. By examining the similarities of the placenta's and tumor's immune cells, novel mechanisms to cause tumors to be eliminated can be devised.
© 2016 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  a2v-ATPase; cancer; placenta; pregnancy; vacuolar ATPase

Mesh:

Year:  2016        PMID: 27293114     DOI: 10.1111/aji.12524

Source DB:  PubMed          Journal:  Am J Reprod Immunol        ISSN: 1046-7408            Impact factor:   3.886


  13 in total

1.  The unique immunological and microbial aspects of pregnancy.

Authors:  Gil Mor; Paulomi Aldo; Ayesha B Alvero
Journal:  Nat Rev Immunol       Date:  2017-06-19       Impact factor: 53.106

Review 2.  Cooperative inflammation: The recruitment of inflammatory signaling in marsupial and eutherian pregnancy.

Authors:  Daniel J Stadtmauer; Günter P Wagner
Journal:  J Reprod Immunol       Date:  2019-10-25       Impact factor: 4.054

3.  Cancer derived peptide of vacuolar ATPase 'a2' isoform promotes neutrophil migration by autocrine secretion of IL-8.

Authors:  Safaa A Ibrahim; Arpita Kulshrestha; Gajendra K Katara; Magdy A Amin; Kenneth D Beaman
Journal:  Sci Rep       Date:  2016-11-15       Impact factor: 4.379

Review 4.  A current perspective on cancer immune therapy: step-by-step approach to constructing the magic bullet.

Authors:  Gabriele D'Errico; Heather L Machado; Bruno Sainz
Journal:  Clin Transl Med       Date:  2017-01-03

5.  Cancer metastasis: enactment of the script for human reproductive drama.

Authors:  Xichun Sun; Xiwu Liu
Journal:  Cancer Cell Int       Date:  2017-05-02       Impact factor: 5.722

Review 6.  Natural Killer Cells in the Orchestration of Chronic Inflammatory Diseases.

Authors:  Luca Parisi; Barbara Bassani; Marco Tremolati; Elisabetta Gini; Giampietro Farronato; Antonino Bruno
Journal:  J Immunol Res       Date:  2017-03-27       Impact factor: 4.818

7.  Villi-specific Gene Expression Reveals Novel Prognostic Biomarkers in Multiple Human Cancers.

Authors:  Botao Zhang; Lin Feng; Honglin Guo; Hongxia Li; Yuanjing Wang; Kaitai Zhang; Xuexin Yu; Shujun Cheng
Journal:  J Cancer       Date:  2017-08-23       Impact factor: 4.207

8.  Villi development core-related gene expression associated with lung squamous cancer prognosis.

Authors:  Liyuan Yin; Yonggang Wang; Guangzhi Ma; Yunfu Deng; Qinghua Zhou
Journal:  Medicine (Baltimore)       Date:  2019-03       Impact factor: 1.817

Review 9.  Pluripotent Stem Cells: Cancer Study, Therapy, and Vaccination.

Authors:  Mojgan Barati; Maryam Akhondi; Narges Sabahi Mousavi; Newsha Haghparast; Asma Ghodsi; Hossein Baharvand; Marzieh Ebrahimi; Seyedeh-Nafiseh Hassani
Journal:  Stem Cell Rev Rep       Date:  2021-06-11       Impact factor: 5.739

10.  Endogenous Retroviruses Drive Lineage-Specific Regulatory Evolution across Primate and Rodent Placentae.

Authors:  Ming-An Sun; Gernot Wolf; Yejun Wang; Anna D Senft; Sherry Ralls; Jinpu Jin; Caitlin E Dunn-Fletcher; Louis J Muglia; Todd S Macfarlan
Journal:  Mol Biol Evol       Date:  2021-10-27       Impact factor: 8.800

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.